Home › Funds › Glendon Capital Management LP › DBD
Glendon Capital Management LP position in DBD
DIEBOLD NIXDORF INC · Miscellaneous
Glendon Capital Management LP reported holding 399,121 shares of DBD (DIEBOLD NIXDORF INC) in its Q3 2026 13F filing — a position valued at US$24.4M, representing 3.55% of its reported portfolio and ranking #10 among its reported holdings. Glendon Capital Management LP has disclosed DBD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Glendon Capital Management LP's DBD position evolved
Glendon Capital Management LP first disclosed a stake in DBD in Q3 2023 at 1,112,653 shares (US$21.1M). The position peaked in Q2 2025 at 1,548,740 shares, worth US$85.8M. Across 13 filings, Glendon Capital Management LP increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 399,121 shares valued at US$24.4M — an increase of 183,553 shares quarter over quarter.. Notable position changes include a 33% trim in Q4 2025 (shares rose 11% over the following quarter), a 73% trim in Q1 2026 (shares rose 13% over the following quarter), a 85% increase in Q3 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.11M | $21.07M | New |
| Q4 2023 | 1.17M | $33.98M | Add |
| Q1 2024 | 1.17M | $40.42M | Hold |
| Q2 2024 | 1.23M | $47.34M | Add |
| Q3 2024 | 1.26M | $56.18M | Add |
| Q4 2024 | 1.32M | $56.73M | Add |
| Q1 2025 | 1.50M | $65.50M | Add |
| Q2 2025 | 1.55M | $85.80M | Add |
| Q3 2025 | 1.18M | $67.20M | Reduce |
| Q4 2025 | 787.31K | $53.45M | Reduce |
| Q1 2026 | 215.57K | $16.26M | Reduce |
| Q2 2026 | 215.57K | $18.33M | Hold |
| Q3 2026 | 399.12K | $24.43M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DBD and 13F data
DBD (DIEBOLD NIXDORF INC) is a Miscellaneous company. 39 other funds we track also report a position in DBD — the largest reported positions include Millstreet Capital Management LLC (US$349.0M), Beach Point Capital Management LP (US$40.8M), Irenic Capital Management LP (US$40.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DBD
- Millstreet Capital Management LLC 4.10M sh · $348.96M · Q2 2026
- Beach Point Capital Management LP 666.93K sh · $40.83M · Q3 2026
- Irenic Capital Management LP 476.52K sh · $40.51M · Q2 2026
- Skylands Capital, LLC 531.51K sh · $32.54M · Q3 2026
- 325 CAPITAL LLC 242.08K sh · $20.58M · Q2 2026
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 217.90K sh · $13.34M · Q3 2026
More on Glendon Capital Management LP
FAQ
How long has Glendon Capital Management LP held DBD?
Glendon Capital Management LP has disclosed DBD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Glendon Capital Management LP's current position in DBD?
As of Q3 2026, Glendon Capital Management LP holds 399.12K shares of DBD (DIEBOLD NIXDORF INC), valued at $24.43M, representing 3.55% of its reported portfolio and ranking #10.
Has Glendon Capital Management LP been buying or selling DBD?
In the latest 13F filing (Q3 2026), Glendon Capital Management LP increased its position in DBD. The position peaked in Q2 2025 at 1.55M shares.
Which other funds hold DBD?
Other major institutional holders of DBD include Millstreet Capital Management LLC, Beach Point Capital Management LP, Irenic Capital Management LP, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.